MedTrace Logo

A Personalized Biomonitoring and Report-back Intervention to Reduce Exposure to Endocrine Disrupting Chemicals

NCT06450951 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2026-05-14

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if a personalized biomonitoring report-back and educational intervention in child-bearing aged men and women can reduce endocrine disrupting chemicals (EDCs) measured in urine, increase participants' understanding of environmental health (environmental health literacy; EHL), increase their readiness and behaviors to reduce exposures, and improve their well-being.

The intervention includes EDC testing and exposure report-back, a self-directed online interactive curriculum with access to live coaches, and an online forum. The investigators hypothesize that the intervention will be more effective than EDC testing and report-back alone at reducing EDC exposures (behavior change and metabolite concentrations), as well as increasing EHL, readiness to reduce exposures, and well-being.

Conditions

  • Environmental Exposure

Interventions

DIAGNOSTIC_TEST

Urinary EDC metabolite testing

Mail-in urine samples tested for metabolites of bisphenols, phthalates, parabens, and oxybenzone.

BEHAVIORAL

Educational curriculum

A self-directed online interactive curriculum of EDC material, with access to live coaches and an online forum.

Sponsors & Collaborators

  • Renown Health

    collaborator OTHER

  • University of Nevada, Reno

    collaborator OTHER

  • Million Marker Wellness, Inc.

    lead INDUSTRY

Principal Investigators

  • Carol Kwaitkowski, PhD · Million Marker Wellness

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
44 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-05-23
Primary Completion
2026-02-28
Completion
2026-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06450951 on ClinicalTrials.gov